Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001493152-22-018360
Filing Date
2022-07-01
Accepted
2022-07-01 16:05:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 formprec14a.htm PREC14A 260920
2 formprec14a_001.jpg GRAPHIC 4414
3 formprec14a_002.jpg GRAPHIC 4405
  Complete submission text file 0001493152-22-018360.txt   274820
Mailing Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022
Business Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022 914-629-8496
Camac Fund, LP (Filed by) CIK: 0001516478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A

Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-40804 | Film No.: 221061371
SIC: 2834 Pharmaceutical Preparations